Insufficient impact of the aldose reductase inhibitor cemtirestat on the skeletal system in type 2 diabetic rat model
PLOS One · 2025
DOI: 10.1371/journal.pone.0336508 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Monika Martiniakova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, Nitra, Slovakia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Aldehyde Reductase, Enzyme Inhibitors, Bone and Bones. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Å¡kolstva, vedy, výskumu a Å¡portu Slovenskej republiky.
Abstract (Originalsprache)
Cemtirestat, a multi-target drug combining aldose reductase inhibition with antioxidant properties, is considered a promising therapeutic agent for chronic diabetic complications. Current evidence suggests that long-standing diabetes adversely affects skeletal health, leading to diabetic bone disease. As the impact of cemtirestat on the skeletal system in an animal model of type 2 diabetes mellitus (T2DM) is still unknown, our study first investigated its effect on impaired bone health in Zucker diabetic fatty (ZDF) rats. Adult rats were divided into four groups: L (untreated lean ZDF rats), D (untreated obese ZDF rats), DT2.5 (obese ZDF rats treated with 2.5 mg/kg/day cemtirestat), and DT7.5 (obese ZDF rats treated with 7.5 mg/kg/day cemtirestat), with cemtirestat treatment lasting 2 months. Group D had increased levels of plasma glucose, insulin, triglycerides, glycated hemoglobin, total cholesterol, alkaline phosphatase, alanine aminotransferase, C-terminal telopeptide of type 1 collagen, greater body weight, femoral weight, structure model index, reduced cortical bone volume fraction, cortical bone thickness, trabecular bone volume fraction, and trabecular thickness compared to group L. Cemtirestat supplementation only elevated plasma phosphate levels in group DT2.5, trabecular bone volume fraction and trabecular thickness in group DT7.5, but the treatment had no effect on other parameters demonstrated in ZDF rats by macroscopic analysis, micro-CT cortical bone analysis, and mechanical testing. These findings indicate that the efficacy of cemtirestat in restoring deteriorated bone health caused by T2DM is not substantiated due to its insufficient effect on the skeletal system in the ZDF rat model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Zoology and Anthropology, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, Nitra, Slovakia.
- Centre of Experimental Medicine, Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia.
- Faculty of Informatics and Information Technologies, Slovak University of Technology in Bratislava, Bratislava, Slovakia.
- Department of Botany and Genetics, Faculty of Natural Sciences and Informatics, Constantine the Philosopher University in Nitra, Nitra, Slovakia.
- Department of Pharmacology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland.
ORCID-Profile: Monika Martiniakova, Vladimira Mondockova
Förderung
- Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
Zitieren
APA
Martiniakova, M., Soltesova Prnova, M., Kovacova, V., Mondockova, V., Svik, K., Londzin, P., Folwarczna, J., & Omelka, R. (2025). Insufficient impact of the aldose reductase inhibitor cemtirestat on the skeletal system in type 2 diabetic rat model. PLOS One. https://doi.org/10.1371/journal.pone.0336508
Vancouver
Martiniakova M, Soltesova Prnova M, Kovacova V, Mondockova V, Svik K, Londzin P, et al. Insufficient impact of the aldose reductase inhibitor cemtirestat on the skeletal system in type 2 diabetic rat model. PLOS One. 2025. doi:10.1371/journal.pone.0336508
BibTeX
@article{Martiniakova2025,
author = {Martiniakova, Monika and Soltesova Prnova, Marta and Kovacova, Veronika and Mondockova, Vladimira and Svik, Karol and Londzin, Piotr and Folwarczna, Joanna and Omelka, Radoslav},
title = {Insufficient impact of the aldose reductase inhibitor cemtirestat on the skeletal system in type 2 diabetic rat model},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0336508}
}
EUVIMED